Влияние различных методов анестезии и анальгезии на отдаленные результаты хирургических вмешательств в онкологии

Влияние различных методов анестезии и анальгезии на отдаленные результаты хирургических вмешательств в онкологии

Автор: Овечкин А.М., Ефременко И.В.

Журнал: Вестник Национального медико-хирургического центра им. Н.И. Пирогова @vestnik-pirogov-center

Рубрика: Обзоры литературы

Статья в выпуске: 4 т.7, 2012 года.

Бесплатный доступ

Короткий адрес: https://sciup.org/140188117

IDR: 140188117

Список литературы Влияние различных методов анестезии и анальгезии на отдаленные результаты хирургических вмешательств в онкологии

  • Горобец Е.С., Гаряев Р.В. Рассуждения о послеоперационном обезболивании и внедрении эпидуральной анальгезии в отечественную хирургическую клинику. Регионарная анестезия и лечение острой боли 2007; 1: 42-51.
  • Любошевский П.А., Забусов А.В. Влияние регионарной анестезии на метаболические и воспалительные изменения при абдоминальных операциях. Общая реаниматология 2011; 2: 31-34.
  • Марченков Ю.В., Рябчиков М.М., Шульгин М.А. Сравнительная характеристика различных видов послеоперационной анальгезии у больных с онкологическими заболеваниями легких. Общая реаниматология 2011; 3: 32-37.
  • Amato A., Pescatori M. Perioperative blood transfusions for the recurrence of colorectal cancer. Cochrane Database Syst. Rev. 2006; 1: CD005033.
  • Bar-Yosef S., Melamed R., Page G. Attenuation of the tumor-promoting effect of surgery by spinal blockade in rats. Anesthesiology 2001; 94: 1066-1073.
  • Beilin B., Shavit Y., Hart J. Effects of anesthesia based on large versus small doses of fentanyl on natural killer cell cytotoxicity in the perioperative period. Anesth. Analg.1996; 82: 492-497.
  • Beilin B., Shavit Y., Razumovsky J. Effect of mild perioperative hypothermia on cellular immune responses. Anesthesiology 1998; 89: 1133-1140.
  • Ben-Eliahu S., Shakhar G., Rosenne E. Hypothermia in barbiturate-anesthetized rats suppresses natural killer cell activity and compromises resistance to tumor metastasis: a role for adrenergic mechanisms. Anesthesiology 1999; 91: 732-740.
  • Ben-Eliahu S. The promotion of tumor metastasis by surgery and stress: immunological basis and implications for psychoneuroimmunology. Brain Behav. Immun. 2003; 17 (Suppl.): P. 27-36.
  • Benish M., Bartal I., Golgfarb Y. Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis. Ann.Surg.Oncol. 2008; 15: 2042-2052.
  • Biki B., Mascha E., Moriarty D. Anesthetic technique for radical prostatectomy surgery affects cancer recurrence: a retrospective analysis. Anesthesiology 2008; 109: 180-187.
  • Brand J., Kirchner H., Poppe C. The effect of general anesthesia on human peripheral immune cell distribution and cytokine production. Clin.Immunol. Immunopathol. 1997; 83: 190-194.
  • Bruzzone A., Pinero C., Castillo L. Alpha2 -adrenoreceptor action on cell proliferation and mammary tumor growth in mice. Br.J.Pharmacol. 2008; 155: 494-504.
  • Chen G., Zhang F., Gong M. Effect of perioperative autologuos versus allogenic blood transfusion on the immune system in gastric cancer patients. J. Zhejiang Univ. Sci. 2007; 8: 560-565.
  • Сhristopherson R., James K., Tableman M.Long-term survival after colon cancer surgery: a variation associated with choice of anesthesia. Anesth.Analg.2008; 107: 325-332.
  • Exadactylos A., Buggy D., Moriarty D. Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis? Anesthesiology 2006; 105: 660-664.
  • Farooqui M., Rogers T., Poonawala T. COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumor growth, metastasis and mortality, without compromising analgesia. Br.J.Cancer. 2007; 97: 1523-1531.
  • Galley H., Dubbels A., Webster N. The effect of midazolam and propofol on interleukin-8 from human polymorphonuclear leucocytes. Anesth.Analg.1998; 86: 1289-1293.
  • Gaspani L., Bianchi M., Limiroli E. The analgesic drug tramadol prevents the effect of surgery on natural killer cell activity and metastatic colonization in rats. J.Neuroimmunol. 2002; 129: 18-24.
  • Goldfarb Y., Ben-Eliahu S. Surgery as a risk factor for breast cancer recurrence and metastasis: mediating mechanisms and clinical prophylactic approaches. Breast. Dis. 2006; 26: 99-114.
  • Gottschalk A., Sharma S., Ford J. The role of the perioperative period in recurrence after cancer surgery. Anesth.Analg. 2010; 110: 1636-1643.
  • Gottschalk A., Ford J., Regelin C. Association between epidural analgesia and cancer recurrence after colorectal cancer surgery. Anesthesiology 2010; 113: 27-34.
  • Gupta G., Massague J. Cancer metastasis: building a framework. Cell 2006; 127: 679-695.
  • Gupta A., Bjornsson A., Fredriksson M. Reduction of mortality after epidural anaesthesia and analgesia in patients undergoing rectal but non colonic cancer surgery: a retrospective analysis of data from 655 patients in Central Sweden. Br.J.Anaesth. 2011; 107: 164-170.
  • Harris R., Beebe-Donk J., Alshafie G. Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors. BMC Cancer 2006; 6: 27.
  • Hasegawa H., Saiki I. Psychosocial stress augments tumor development through beta-adrenergic activation in mice. Jpn.J.Cancer Res. 2002; 93: 729-735.
  • Inada T., Ymanaoichi Y., Jomura S. Effect of propofol and isoflurane Anaesthesia on the immune response to surgery. Anaesthesia 2004; 59: 954-959.
  • Inada T., Kubo K., Kambara T. Propofol inhibits cyclo-oxygenase activity in human monocytic THP-1 cells. Can.J.Anaesth. 2009; 56: 222-229.
  • Jones M., Wang H., Pescar B. Inhibition of angiogenesis by nonsteroidal antiinflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nat.Med. 1999; 5: 1418-1423.
  • Ke J., Zhan J., Feng X. A comparison of the effect of total intravenous anesthesia with propofol and remifentanil and inhalation anesthesia with isoflurane on the release of pro-and anti-inflammatory cytokines in patients undergoing open cholecystectomy. Anaesth.Intensive Care 2008; 36: 74-78.
  • Kundu J., Surh Y. Inflammation: gearing the journey to cancer. Mutat Res. 2008; 659: 15-30.
  • Kushida A., Inada T., Shingu K. Enhancement of antitumor immunity after propofol treatment in mice. Immunopharmacol.Immunotoxicol. 2007; 29: 477-486.
  • Leahy K., Ornberg R., Wang Y. Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo. Cancer Res. 2002; 62: 625-631.
  • Lutgendorf S., Cole S., Costanzo E. Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines. Clin.Cancer.Res. 2003; 9: 4514-4521.
  • Mammoto T., Mukai M., Mammoto A. Intravenous anesthetic propofol inhibits invasion of cancer cells. Cancer Lett. 2002; 184: 165-170.
  • Mammoto T., Higashiyama S., Mukai M. Infiltration anesthetic lidocaine inhibits cancer cell invasion by modulation ectodomain shedding of heparin-binding epidermal growth factor-like growth factor (HB-EGF). J.Cell. Physiol. 2002; 192: 351-358.
  • Markovic S., Knidht P., Murasko D. Inhibition of interferon stimulation of natural killer cell activity in mice anesthetized with halothane or isoflurane. Anesthesiology 1993; 78: 700-706.
  • Martinsson T. Ropivacaine inhibits serum-induced proliferation of colon adenocarcinoma cells in vitro. J.Pharmacol.Exp.Ther. 1999; 288: 660-664.
  • Melamed R., Bar-Yosef S., Shakhar G. Supression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental and halothane, but not by propofol: mediating mechanisms and prophylactic measures. Anesth.Analg. 2003; 97: 1331-1339.
  • Melamed R., Rosenne E., Shakhar K. Marginating pulmonary NK-activity and resistance to experimental tumor metastasis: suppression by surgery and the prophylactic use of a beta-adrenergic antagonist and a prostaglandin synthesis inhibitor. Brain Behav.Immun. 2005; 19: 114-126.
  • Mitsuhata H., Shimizu R., Yokoyama M. Suppressive effects of volatile anesthetics on cytokine release in human peripheral blood mononuclear cells. Int.J.Jmmunopharmacol. 1995; 17: 529-534.
  • Page G., Blakely W., Ben-Eliahu S. Evidence that postoperative Pain is a mediator of the tumor-promoting effects of surgery in rats. Pain 2001; 90: 191-199.
  • Procopio M., Rassias A., DeLeo J. The in vivo effects of general and epidural anesthesia on human immune function. Anesth.Analg. 2001; 93: 460-465.
  • Roche-Nagle G., Connolly E., Eng M. Antimetastatic activity of a cyclooxygenase-2 inhibitor. Br.J.Cancer. 2004; 91: 359-365.
  • Sacerdote P., Bianchi M., Gaspani L. The effects of tramadol and morphine on immune responses and pain after surgery in cancer patients. Anesth.Analg. 2000; 90: 1411-1414.
  • Sakaguchi M., Kuroda Y., Hirose M. The antiproliferative effect of lidocaine of human tongue cancer with inhibition of the activity of epidermal growth factor receptor. Anesth.Analg. 2006; 102: 1103-1107.
  • Schlagenhauff B., Ellwanger U., Breuninger H. Prognostic impact of the type of anaesthesia used during the excision of primary cutaneous melanoma. Melanoma Res. 2000; 10: 165-169.
  • Sessler D. Does regional analgesia reduce the risk of cancer recurrence? A hypothesis. Eur.J.Cancer. Prev. 2007; 17: 269-272.
  • Shavit Y., Ben-Eliahu S., Zeidel A. Effects of fentanil on natural killer cell activity and on resistance to tumor metastasis in rats. Dose and timing study. Neuroimmunomodulation. 2004; 11: 255-260.
  • Smith T., Staats P., Deer T. Implantable drug delivery systems study group: randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity and survival. J.Clin.Oncol. 2002; 20: 4040-4049.
  • Sood A., Bhatty R., Kamat A. Stress hormone-mediated invasion of ovarian cancer cells. Clin.Cancer.Res.2006; 12: 369-375.
  • Thaker P., Han L., Kamat A. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat.Med. 2006; 12: 939-944.
  • Thaker P., Sood A. Neuroendocrine influences on cancer biology. Semin. Cancer. Biol. 2008; 18: 164-170.
  • Tsuchiya M., Asada A., Arita K. Induction and mechanism of apoptotic cell death by propofol in HL-60 cells. Acta Anaesth.Scand. 2002; 46: 1068-1074.
  • Wada H., Seki S., Takahashi T. Combined spinal and general anesthesia attenuates liver metastasis by preserving TH1/TH2 cytokine balance. Anesthesiology 2007; 106: 499-506.
  • Weber R., Jabbour N., Martin R. Anemia and transfusions in patients undergoing surgery for cancer. Ann.Surg.Oncol. 2008; 15: 34-45.
  • Weimann J. Toxicity of nitrous oxide. Best.Pract.Res. 2003; 17: 47-61.
  • Wojtowicz-Praga S. Reversal of tumor-induced immunosupression by TGF-beta inhibitors. Invest. New Drugs. 2003; 21: 21-32.
  • Yeager M., DeLeo J., Arruda J. Intravenous fentanil increases natural killer cel cytotoxicity and circulating CD16+ lymphocytes in humans. Anesth. Analg. 2002; 94: 94-99.
Еще
Статья обзорная
SciUp 2024 © 2024 ©